Acute Lymphoblastic Leukemia (ALL) Clinical Trials

Find Acute Lymphoblastic Leukemia (ALL) Clinical Trials Near You

Characterizing Sleep Among Long-term Survivors of Childhood Cancer

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test, Other, Device
Study Type: Observational
SUMMARY

The patients are being asked to take part in this clinical trial because they received cancer treatment as a child at St. Jude. The study comprehensively examines sleep among three distinct diagnostic groups of survivors in the SJLIFE cohort: ALL, CNS tumors, and non-CNS solid tumors. Primary Objective The primary aim of this protocol is to estimate the prevalence of various sleep disorders among long-term survivors of childhood ALL, CNS tumors, and non- CNS solid tumors. Exploratory Objective The exploratory objective of the study is to explore associations between the prevalence of sleep disorders and clinical outcomes collected in SJLIFE.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Participant in SJLIFE and \> 5 years from diagnosis.

• \>18 years of age at time of enrollment.

• Diagnosed with ALL (treated with CRT or chemotherapy only) or CNS tumors (posterior fossa tumors or supratentorial tumors) or non-CNS solid tumors (with abdominal or chest radiation or bilateral retinoblastoma survivors).

• Participant was less than 21 years of age at time of diagnosis.

• Speaks and understands English (polysomnography device speaks to patients only in English).

• Remote participant must have Wi-Fi access

Locations
United States
Tennessee
St. Jude Children's Research Hospital
RECRUITING
Memphis
Contact Information
Primary
Kevin Krull, PhD
referralinfo@stjude.org
866-278-5833
Time Frame
Start Date: 2023-04-17
Estimated Completion Date: 2027-01
Participants
Target number of participants: 120
Treatments
On campus
SJLIFE Study Campus Visit
Remote
SJLIFE cohort: ALL, CNS tumors, and non-CNS solid tumors
Sponsors
Leads: St. Jude Children's Research Hospital

This content was sourced from clinicaltrials.gov